Fagron NV (ARSUF)

18.59 0.00 (0.00%) At close: 01:04PM EDT

Fagron NV

Venecoweg 20A
Nazareth 9810
Belgium
32 8 001 28 80
https://www.fagron.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 3,282

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Rafael Padilla	CEO & Executive Director	1.2M	N/A	1978
Ms. Karin de Jong	CFO & Executive Director	708.14k	N/A	1979
Ms. Vera Bakker	Chief Operating Officer	8k	N/A	1972
Karen Berg	Global Investor Relations Manager	N/A	N/A	N/A
Mr. Johan Verlinden	Head of Legal, Mergers & Acquisitions	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Corporate governance

Fagron NV’s ISS governance QualityScore as of 1 April 2024 is 5. The pillar scores are Audit: 7; Board: 6; Shareholder rights: 4; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.